Arun Azad

34PUBLICATIONS

151CO-AUTHORS

Radiation therapyMolecular targetsPredictive and prognostic markersToxicology (incl. clinical toxicology)Pharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|Jul 08, 2026

Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

|Jul 02, 2026

Germline CDK12 variants in aggressive prostate cancer.

|Jun 26, 2026

AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Apr 14, 2026

Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer.

Abdullah Al-Khanaty, David Chen, Jonathan Walbaum

|Apr 14, 2026

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.

Arun A Azad, Neeraj Agarwal, Andrew J Armstrong

|Apr 14, 2026

From salvage to spotlight: how 2025 transformed PSMA radioligand therapy.

Abdullah Al-Khanaty, Carlos Delgado, Francisco Valencia

Pageof 6

Frequent Collaborators

Michael S Hofman

Declan G Murphy

Edmond M Kwan

Neeraj Agarwal

Ian D Davis

Neal D Shore

Gail P Risbridger

Andrew J Armstrong

Hui-Ming Lin

Anthony M Joshua

Frequent Collaborators

Michael S Hofman

Declan G Murphy

Edmond M Kwan

Neeraj Agarwal